Interleukin-1 and inflammatory neurodegeneration
- PMID: 17956293
- DOI: 10.1042/BST0351122
Interleukin-1 and inflammatory neurodegeneration
Abstract
Inflammation occurs rapidly in response to acute brain insults such as stroke, haemorrhage or trauma, and can be sustained for long periods of time, for example in Alzheimer's or Parkinson's diseases and multiple sclerosis. Experimental evidence indicates that inflammation plays a major role in neurodegeneration under these conditions, and that the cytokine IL-1 (interleukin-1) is a pivotal mediator. IL-1 is expressed rapidly in response to neuronal injury, predominantly by microglia, and elevated levels of endogenous or exogenous IL-1 markedly exacerbate injury. The naturally occurring IL-1RA (IL-1 receptor antagonist) markedly inhibits ischaemic, excitotoxic and traumatic brain injury in rodents, and has shown promise in a Phase II clinical trial in stroke patients. The mechanisms of IL-1 expression, release and action in neurodegeneration are not fully elucidated and appear multiple. Systemic IL-1 markedly enhances ischaemic brain injury via release of neutrophils into circulation, neutrophil adhesion to injured cerebrovasculature and CNS (central nervous system) invasion, and cell death via activation of matrix metalloproteinase-9. IL-1 also influences the release of toxins from glial and endothelial cells. Neuronal responses to excitotoxins and physiological factors may have an impact on neuronal survival. IL-1RA, delivered peripherally, can enter the CNS in animals and humans and has no adverse effects in stroke or subarachnoid haemorrhage patients, but shows potential benefit in acute stroke patients.
Similar articles
-
Interleukin 1 in the brain: biology, pathology and therapeutic target.Trends Neurosci. 2000 Dec;23(12):618-25. doi: 10.1016/s0166-2236(00)01661-1. Trends Neurosci. 2000. PMID: 11137152 Review.
-
Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage.Br J Clin Pharmacol. 2008 Mar;65(3):317-25. doi: 10.1111/j.1365-2125.2007.03026.x. Epub 2007 Sep 13. Br J Clin Pharmacol. 2008. PMID: 17875190 Free PMC article.
-
Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential.Brain Behav Immun. 2003 Jun;17(3):152-7. doi: 10.1016/s0889-1591(02)00098-3. Brain Behav Immun. 2003. PMID: 12706413 Review.
-
The interleukin-1 system: an attractive and viable therapeutic target in neurodegenerative disease.Curr Drug Targets CNS Neurol Disord. 2003 Oct;2(5):293-302. doi: 10.2174/1568007033482742. Curr Drug Targets CNS Neurol Disord. 2003. PMID: 14529361 Review.
-
The role of pro- and antiinflammatory cytokines in neurodegeneration.Ann N Y Acad Sci. 2000;917:84-93. doi: 10.1111/j.1749-6632.2000.tb05373.x. Ann N Y Acad Sci. 2000. PMID: 11268414 Review.
Cited by
-
Integrating pathways of Parkinson's disease in a molecular interaction map.Mol Neurobiol. 2014 Feb;49(1):88-102. doi: 10.1007/s12035-013-8489-4. Epub 2013 Jul 7. Mol Neurobiol. 2014. PMID: 23832570 Free PMC article. Review.
-
Tetrabromobisphenol A and hexabromocyclododecane alter secretion of IL-1β from human immune cells.J Immunotoxicol. 2016 May;13(3):403-16. doi: 10.3109/1547691X.2015.1111960. Epub 2015 Nov 19. J Immunotoxicol. 2016. PMID: 27297965 Free PMC article.
-
Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer's disease: a randomized phase 1 study.BMC Med. 2023 Nov 23;21(1):459. doi: 10.1186/s12916-023-03126-9. BMC Med. 2023. PMID: 37996817 Free PMC article. Clinical Trial.
-
Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia.Expert Rev Neurother. 2016 Nov;16(11):1251-1262. doi: 10.1080/14737175.2016.1203257. Epub 2016 Jul 11. Expert Rev Neurother. 2016. PMID: 27314601 Free PMC article. Review.
-
The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro.J Neuroinflammation. 2010 Jan 14;7:4. doi: 10.1186/1742-2094-7-4. J Neuroinflammation. 2010. PMID: 20074365 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical